 Changes plasma homovanillic acid concentrations schizophrenic patients neuroleptic discontinuation Changes plasma levels dopamine metabolite homovanillic acid changes severity schizophrenic symptoms neuroleptic administration neuroleptic discontinuation study effects discontinuation neuroleptic treatment plasma homovanillic acid levels patients chronic schizophrenia clinical decompensation increased plasma homovanillic acid levels Plasma homovanillic acid administration neuroleptic medication subsequent drug-free period Nine patients drug-free period patients drug discontinuation homovanillic acid concentrations schizophrenic patients peak plasma homovanillic acid elevation discontinuation neuroleptic medication peak Brief Psychiatric Rating Scale increase data suggest schizophrenic patients symptomatic decompensation discontinuation neuroleptic treatment increases dopamine turnover